REDHAWK ANNOUNCES NEW
ORDERS TOP
$12.0
MILLION
Revenues for Twelve Months Ended December 31, 2020
Increased More Than
1000%
LAFAYETTE, LA -- February 5, 2021 --
InvestorsHub NewsWire -- RedHawk Holdings
Corp. (OTC:
SNDD) ("RedHawk" or the
"Company"), a diversified holding
company primarily engaged in sales and distribution of
medical devices and certain personal protection
equipment, announced
today
gross
revenues for the
twelve month period ended December 31, 2020 were approximately
$2.0 million, an increase of
approximately $1.8 million
over
the
comparable twelve month period ended December 31, 2019.
Net
revenues were approximately $1.7 million, more than 1000%
higher than
net revenues for
the comparable twelve month period ended December 31, 2019.
The Company's
fiscal year end is June 30, and, therefore, these
gross revenues and
net revenues represent results from the Company's third and fourth
fiscal quarters of the fiscal year ended June 30, 2020
together
with the
first and second fiscal quarters of the Company's current fiscal
year.
The
increases in gross revenues and net
revenues during the twelve month period
ended December 31, 2020 were primarily a result
of greater
sales of SANDD™, the Company's propriety line of needle
incineration medical devices, and certain personal
protection equipment. To date, increased sales of our medical
products have continued after December 31,
2020.
Currently, new orders for future sales of our medical
devices and certain personal protection equipment
now exceed $12.0 million with further increases
possible as order quotations and inquiries appear strong.
Commenting on the projected revenues
for the twelve month period ending December 31, 2021, G. Darcy
Klug, RedHawk Chairman and Chief Financial Officer, said,
"During the
three month period ended December 31, 2020, we started the
re-alignment our medical device marketing strategy to increase
product awareness while meeting the demands of current market
conditions and customer demands. Our medical products business unit
continues to
operate in a challenging workplace environment due to implemented COVID-19
protocols by
hospitals, clinics, and other medical offices. Most of our target customers
will not schedule in-person appointments with our sales
representatives. This change in marketing
strategy has been very successful to date
and is expected to
be fully completed during the three month period
ending March 31, 2021."
# # #
About RedHawk Holdings Corp.
RedHawk Holdings Corp., formerly Independence Energy Corp., is
a diversified holding company which, through its subsidiaries, is
engaged in the sales and distribution of
medical devices, sales of branded generic
pharmaceutical drugs, commercial real estate
investment and leasing, sales of point of entry
full-body security systems, and specialized
financial services. Through its medical
products business unit, the Company sells
the Sharps and Needle Destruction Device
(SANDD™), WoundClot Surgical - Advanced Bleeding
Control, and the Carotid Artery
Digital Non-Contact Thermometer. Through our
United Kingdom based subsidiary, we manufacture and market branded
generic pharmaceuticals. RedHawk Energy holds the
exclusive U.S. manufacturing and distribution rights for the Centri
Controlled Entry System, a unique, closed cabinet, nominal dose
transmission full-body x-ray scanner. For more
information, please visit: http://www.redhawkholdingscorp.com
Cautionary Statement Regarding Forward-Looking
Statements
This release may contain forward-looking statements.
Forward-looking statements are all statements other than
statements of historical fact. Statements contained in
this release that are not historical facts may be deemed to be
forward-looking statements. The words "anticipate," "may," "can,"
"plans," "believes," "estimates," "expects," "projects," "targets,"
"intends," "likely," "will," "should," "to be,"
"potential" and any similar expressions are intended to identify
those assertions as forward-looking statements.
Investors are cautioned that forward-looking statements are
inherently uncertain. Actual performance and results may
differ materially from that projected or suggested herein due to
certain risks and uncertainties. In evaluating
forward-looking statements, you should consider the various factors
which may cause actual results to differ materially from any
forward-looking statements including those listed in the
"Risk Factors" section of our latest 10-K report. Further,
the Company may make changes to its business plans that could or
will affect its results. Investors are cautioned that the Company
will undertake no obligation to update any forward-looking
statements.
Company
Contact:
G. Darcy
Klug, Chairman and CFO
(337)
269-5933
darcy.klug@redhawkholdingscorp.com
Philip C.
Spizale, CEO
(337)
269-5933
philip.spizale@redhawkholdingscorp.com
Investor
Relations:
Stephanie
Prince, Managing Director
PCG
Advisory
(646)
762-4518
sprince@pcgadvisory.com
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Aug 2024 to Sep 2024
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Sep 2023 to Sep 2024